BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 19/08/2021

Galephar Pharmaceutical Research Inc. Seeks Registration as Controlled Substance Importer

Galephar Pharmaceutical Research Inc. has submitted an application to the U.S. government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Source: Federal Register — Justice DepartmentOpen original release →